MEDP
Get informed when a big investor buys or sells
+ FollowUndervalued by 3.4% based on the discounted cash flow analysis.
| Market cap | $16.40 Billion |
|---|---|
| Enterprise Value | $16.92 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $15.64 |
| Beta | 1.15 |
| Outstanding Shares | 28,308,000 |
| P/E Ratio | 33.78 |
|---|---|
| PEG | 98.05 |
| Price to Sales | 6.0 |
| Price to Book Ratio | 39.17 |
| Enterprise Value to Revenue | 6.08 |
| Enterprise Value to EBIT | 29.08 |
| Enterprise Value to Net Income | 34 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 2.36 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 5.1076▲ 325.07% |
|---|---|
| Total Calls | 34,400▲ 44.51% |
| Total Puts | 175,700▲ 297.51% |
Holdings and activity of institutional investors.
| Ownership % | 88.55%▲ 3.80% |
|---|---|
| Total Invested | $13.18B▲ 14.10% |
| Investors Holding | 710▼ 32.00% |
No data